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Abstract: Due to the widespread access to, and implementation of, combination antiretroviral
therapy, individuals perinatally infected with human immunodeficiency virus type 1 (HIV-1) are
living into adolescence and adulthood. Perinatally infected adolescents living with HIV-1 (pALHIV)
are plagued by progressive, chronic neurocognitive impairments; the pathophysiological mechanisms
underlying these deficits, however, remain understudied. A longitudinal experimental design from
postnatal day (PD) 30 to PD 180 was utilized to establish the development of pyramidal neurons,
and associated dendritic spines, from layers II-III of the medial prefrontal cortex (mPFC) in HIV-1
transgenic (Tg) and control animals. Three putative neuroinflammatory markers (i.e., IL-1β, IL-6,
and TNF-α) were evaluated early in development (i.e., PD 30) as a potential mechanism underlying
synaptic dysfunction in the mPFC. Constitutive expression of HIV-1 viral proteins induced prominent
neurodevelopmental alterations and progressive synaptodendritic dysfunction, independent of
biological sex, in pyramidal neurons from layers II-III of the mPFC. From a neurodevelopmental
perspective, HIV-1 Tg rats exhibited prominent deficits in dendritic and synaptic pruning. With
regards to progressive synaptodendritic dysfunction, HIV-1 Tg animals exhibited an age-related
population shift towards dendritic spines with decreased volume, increased backbone length, and
decreased head diameter; parameters associated with a more immature dendritic spine phenotype.
There was no compelling evidence for neuroinflammation in the mPFC during early development.
Collectively, progressive neuronal and dendritic spine dysmorphology herald synaptodendritic
dysfunction as a key neural mechanism underlying chronic neurocognitive impairments in pALHIV.
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1. Introduction
Reports of children diagnosed with acquired immune deficiency syndrome (AIDS)
occurred early in the pandemic [1,2]. Invariably, the disease was associated with high mortality rates [3]. However, with widespread access to, and implementation of, combination
antiretroviral therapy (cART), pediatric human immunodeficiency virus type 1 (HIV-1)
evolved from a fatal disease to a chronic disease (e.g., [4,5]). Consequently, the epidemiological features of pediatric HIV-1 have shifted, resulting in a growing population of perinatally
infected adolescents living with HIV-1 (pALHIV). Indeed, approximately 2.78 million children and adolescents (0–19 years of age) are living with either perinatally or horizontally
acquired HIV-1 [6]. Despite the disproportionate number of adolescents affected by HIV-1
worldwide, neurodevelopmental outcomes of pALHIV remain understudied [7].
Neurodevelopment, a dynamic, albeit protracted, process beginning during the gestational period and continuing through late adolescence, refers to the maturation of neural
circuits that influence cognitive functioning (for review, [8]). Early pre- and postnatal brain
development occurs via a precisely orchestrated and timed series of events, including
neuronal production, migration, and differentiation, as well as myelination and synaptogenesis [8]; events which permit the establishment of neural circuits. Subsequent regressive
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events, including programmed cell death [9,10], synaptic pruning [11,12], and dendritic
pruning [13], aid in the refinement of neural circuits resulting in the formation of mature
connections. Notably, the time course of such progressive and regressive events varies
considerably across the cerebral cortex, whereby the prefrontal cortex (PFC) is one of the
last to mature.
Whereas the basic cytoarchitecture of the PFC is defined by birth in humans (for
review, [14]) and postnatal day (PD) 10 in rodents [15], its fine development continues
through adolescence and young adulthood. Specifically, following neuronal proliferation
and migration, cortical nerve cells extend their axons, undergo dendritic arborization,
and form dendritic spines [16], enabling the assembly of immature neural circuits. The
initial patterning of neural circuits in the PFC reflects exuberant connectivity, evidenced
by the formation of an excessive number of synaptic contacts; synaptic contacts which are
subsequently pruned during adolescence and young adulthood [11,12], coinciding with
the development of higher-order cognitive processes. Chronic HIV-1 viral protein exposure
may disrupt these events, fundamentally altering neurodevelopment in the PFC resulting
in profound progressive neurocognitive impairments [17,18].
Indeed, chronic neurocognitive impairments [19] are a highly prevalent [20] and deleterious consequence of perinatally acquired HIV-1. Cross-sectional studies have provided
a wealth of knowledge on chronic neurocognitive impairments, characterized by prominent deficits in cognitive functions that are dependent upon the integrity of the PFC (e.g.,
processing speed [21], attention [22], and executive function [23]). Evaluating neurodevelopmental outcomes, however, necessitates the utilization of a longitudinal experimental
design; extrapolating cross-sectional findings to developmental processes is inferentially
fraught [24]. Thus, repeated evaluation of neurocognitive function across time has been
essential for establishing the progressive nature of chronic neurocognitive impairments
associated with perinatally acquired HIV-1 [17,18,25]. Longitudinal experimental designs,
however, remain underutilized for the investigation of the pathophysiological mechanisms
underlying progressive chronic neurocognitive impairments, albeit with the exception of
a recent manuscript [26].
To address this knowledge gap, two interrelated aims were investigated. First, a longitudinal experimental design (PD 30 to PD 180) was utilized to establish the development
of pyramidal neurons, and associated dendritic spines, from layers II-III of the medial
PFC (mPFC) in the HIV-1 transgenic (Tg) rat. Profound synaptodendritic loss and/or
dysfunction has been observed in HIV-1 seropositive individuals [27,28] and biological systems used to model key aspects of HIV-1 (e.g., [18,29,30]); neurodevelopmental alterations
in pyramidal neurons and/or dendritic spines, however, have not been systematically
evaluated. Given the fundamental role of experience on neuronal and dendritic spine
morphology (e.g., [31,32]), synaptodendritic alterations were evaluated in HIV-1 Tg and
control animals with no prior cognitive or behavioral testing. Second, neuroinflammatory
markers (i.e., IL-1β, IL-6, and TNF-α) were evaluated in the PFC at PD 30 to evaluate
a potential mechanism underlying synaptodendritic dysfunction (e.g., IL-6: [33]).
2. Materials and Methods
2.1. Animals
Control (Fischer F344/N; Envigo Laboratories Inc., Indianapolis, IN, USA) animals
were delivered to the animal vivarium and pair- or group-housed with animals of the same
sex until sacrifice. HIV-1 Tg animals were bred on a Fischer F344/N background at the
University of South Carolina by pairing a control female with an HIV-1 Tg male. Originally
reported in 2001 by Reid et al. [34], the transgene integral to the HIV-1 Tg rat contains a
gag and pol deleted provirus regulated by the human viral promotor. HIV-1 viral proteins
are expressed throughout the body (e.g., blood, lymph nodes, spleen) and in the central
nervous system constitutively throughout development [34,35]. Specifically, the HIV-1
viral proteins Tat, gp120, nef, and vif are expressed in multiple brain regions, including the
prefrontal cortex, striatum, and hippocampus [35]. Furthermore, HIV-1 mRNA expression
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2.3. Experiment #1: Neurodevelopmental Alterations in the Medial Prefrontal Cortex (mPFC)
Pyramidal neurons, and associated dendritic spines, from layers II-III of the mPFC
were examined to establish neurodevelopmental alterations in the mPFC. HIV-1 Tg and
control animals were sacrificed every 30 days from PD 30 to PD 180 utilizing samples sizes
of n = 40 for each age (i.e., Control: Male, n = 10, Female, n = 10; HIV-1 Tg: Male, n = 10,
Female, n = 10). Ages were selected based on deficits observed in previous imaging [26]
and cognitive [17,37,38] studies. Specifically, the earliest timepoint (i.e., PD 30) was selected
following reports that presence of the HIV-1 transgene induced alterations in brain volume
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development early in life (i.e., 5–9 weeks of age [26]). The study endpoint (i.e., PD 180)
reflects an age whereby the HIV-1 Tg rat exhibits prominent neurocognitive impairments
relative to control animals (e.g., [17,37,38]).
2.3.1. Body Weight
Body weight, a measurement of somatic growth, was assessed immediately prior to
sacrifice. Independent of biological sex, HIV-1 Tg animals weighed significantly less than
control animals from PD 30 to PD 180.
Body weight for both male and female animals, independent of genotype, was welldescribed by a one-phase association (Supplementary Figure S1; R2 s ≥ 0.86). For male
animals, presence of the HIV-1 transgene significantly altered the plateau of the function
(F(1,106) = 14.1, p ≤ 0.001), but not the rate of growth (i.e., no statistically significant effect of
genotype on the rate constant, K (p > 0.05)). For female animals, HIV-1 Tg animals exhibited
a significantly lower y-intercept (F(1,108) = 10.4, p ≤ 0.001) and plateau (F(1,108) = 7.2,
p ≤ 0.01), but no statistically significant differences in the rate of growth (p > 0.05). At
sacrifice, therefore, there was strong evidence for the relative health of the HIV-1 Tg rat.
2.3.2. Estrous Cycle Tracking
A vaginal lavage was conducted immediately prior to sacrifice to evaluate the current
estrous cycle stage. Cellular cytology was examined in vaginal smears, as previously
described [39], under a 10x light microscope. The predominant cell type was utilized to
determine the estrous cycle stage, whereby the diestrus phase was characterized by the
predominance of leukocytes [40]. The goal was to sacrifice female animals during the
diestrus phase of the estrous cycle to reduce potential variability due to hormonal cycle.
2.3.3. Ballistic Labeling Technique
Methodology for the ballistic labeling technique was initially described by Seabold et al. [41]
and was adapted for use in our laboratory by Roscoe et al. [30]; a protocol that was further
refined by Li et al. [42].
In brief, the DiI/Tungsten bead tubing was created by dissolving polyvinylpyrrolidone
(PVP; 100 mg) in ddH2 O (10 mL). Tefzel tubing (Bio-Rad, Hercules, CA, USA) was filled
with the PVP solution for 20 min and then expelled. DiOlistic cartridges were prepared
by dissolving tungsten beads (170 mg; Bio-Rad) with 99.5% methylene chloride (250 µL;
Sigma-Aldrich, St. Louis, MO, USA); the tungsten bead suspension was vortexed to
mix thoroughly. Additionally, DiIC18(3) dye (6 mg; Invitrogen, Carlsbad, CA, USA)
was dissolved in 99.5% methylene chloride (300 µL) and vortexed. The tungsten bead
suspension was pipetted onto a glass slide and allowed to dry. After pipetting the DiIC18(3)
dye solution on top of the tungsten bead suspension, the two layers were mixed; the
tungsten bead suspension/DiIC18(3) dye mixture was split into two 1.5 mL centrifuge
tubes filled with ddH2 O and sonicated. The homogenized mixture in the 1.5 mL centrifuge
tubes was combined into a 15 mL conical tube, further sonicated, drawn into the PVP-coated
Tefzel tubing, and fed into the tubing preparation station (Bio-Rad). After the PVP-coated
Tefzel tubing with the homogenous tungsten bead suspension/DiIC18(3) dye mixture (i.e.,
DiOlistic cartridge) rotated for one minute, all water was removed. Rotating continued
for an additional 30 min under nitrogen gas (0.5 L per minute). Once dried, the DiOlistic
cartridges were cut into 13 mm lengths and stored in the dark until subsequent use.
HIV-1 Tg and control animals were deeply anesthetized using 5% sevoflurane (Abbot
Laboratories, North Chicago, IL, USA) and transcardially perfused. The rat brain was
removed, postfixed in 4% paraformaldehyde for 10 min and cut coronally (500 µm) using
a rat brain matrix (ASI Instruments, Warren, MI, USA). Coronal slices were placed into a
24 well-plate with 100 mM phosphate-buffered saline (PBS; 1 mM). Before ballistic labeling,
the PBS was removed from the well-plate.
Ballistic labeling was conducted using the Helios gene gun (Bio-Rad), which was
loaded with previously prepared DiOlistic cartridges. A piece of filter paper was placed be-
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2.3.5. Neuronal Analysis and Spine Quantification
Neuronal morphology and dendritic spines were analyzed using sophisticated neuronal reconstruction software (Neurolucida 360, MicroBrightfield, Williston, VT, USA). All
neurons were coded prior to analysis. Selection criteria (e.g., continuous dendritic staining,
low background/dye clusters), illustrated in Li et al. [42], were used to select one neuron
from each animal for analysis. Neurons not meeting the selection criteria were not included
in the analysis, yielding the following sample sizes: Control: PD 30, n = 19 (male, n = 9,
female, n = 10), PD 60, n = 19 (male, n = 10, female, n = 9), PD 90, n = 18 (male, n = 10,
female, n = 8), PD 120, n = 17 (male, n = 9, female, n = 8), PD 150, n = 18 (male, n = 8, female,
n = 10), PD 180, n = 20 (male, n = 9, female, n = 11); HIV-1 Tg: PD 30, n = 19 (male, n = 10,
female, n = 9), PD 60, n = 19 (male, n = 10, female, n = 9), PD 90, n = 18 (male, n = 8, female,
n = 10), PD 120, n = 20 (male, n = 10, female, n = 10), PD 150, n = 19 (male, n = 9, female,
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n = 10), PD 180, n = 18 (male, n = 9, female, n = 9). Following selection, the apical dendrite
of pyramidal neurons from layers II-III of the mPFC was examined.
Morphological characteristics of pyramidal neurons from layers II-III of the mPFC
were examined using three approaches, including apical dendrite length, Sholl analysis [44]
and centrifugal branch ordering. The classical Sholl analysis affords an opportunity to
examine neuronal arbor complexity by counting the number of dendritic intersections occurring at successive concentric circles placed fixed distances (i.e., 10 µm) from the soma. A
centrifugal branch ordering scheme assigned each dendrite with a branch order by counting
the number of segments traversed; an assessment of dendritic branching complexity.
The morphology of dendritic spines was characterized by three parameters, including
volume (µm3 ), backbone length (µm), and head diameter (µm). Boundary conditions
for each parameter were established using well-accepted previously published results
(volume, 0.05 to 0.85 µm: [45]; backbone length, 0.4 to 4.0 µm: [46,47]; head diameter,
0 to 1.2 µm: [48]). Dendritic spines recognized by the sophisticated neuronal software,
but failing to meet any of the boundary conditions, were excluded from dendritic spine
morphological analyses.
2.4. Experiment #2: Neuroinflammatory Markers in the Medial Prefrontal Cortex (mPFC)
Neuroinflammation was assessed in the mPFC of HIV-1 Tg (n = 20; Male, n = 10,
Female, n = 10) and control (n = 20; Male, n = 10, Female, n = 10) animals at PD 30
using real-time polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent
assays (ELISA).
2.4.1. Sacrifice
HIV-1 Tg and control animals were humanely euthanized and sacrificed by rapid
decapitation. Brains were removed and the frontal cortex was dissected and stored at
−80 ◦ C until being utilized for either RT-PCR or ELISA.
2.4.2. Real-Time Polymerase Chain Reaction (RT-PCR)
The RNeasy FFPE kit (QIAGEN, Germantown, MD, USA) was utilized to isolate
the total RNA from 30 mg of mPFC tissue. Using the Invitrogen (Carlsbad, CA, USA)
Cloned AMV First-Strand cDNA Synthesis Kit, one µg of total RNA from each sample was
converted into cDNA. Details regarding the cDNA synthesis reaction mixture are available
in McLaurin et al. [18].
Subsequently, three neuroinflammatory markers, including IL-1β, IL-6, and TNF-α
were quantified using real-time PCR and the SsoAdvanced Universal SYBR Green Supermix
Kit (BIO-RAD, Hercules, CA, USA). β-actin was used as an internal control. Methodological
details are available in McLaurin et al. [18]. Animals failing to reach threshold after 40 cycles
were considered to have undetectable gene expression and accordingly these censored
data were not included in the figures or statistical analysis, yielding Control, n = 20, male,
n = 10, female, n = 10, and HIV-1 Tg n = 13–19, male, n = 6–10, female, n = 7–9, dependent
upon gene. Data were analyzed using Intuitive Opticon Monitor TM software.
2.4.3. Enzyme-Linked Immunosorbent Assay (ELISA)
Brain tissue lysates were prepared from 12–54 mg of fresh frozen PFC tissue. RIPA
Lysis and Extraction Buffer (1×, Thermo Scientific, Waltham, MA, USA) were added to
extract protein from the brain tissue. Tissue was disrupted using hand sonication. Lysates
were subsequently centrifuged (14,400 rpm at 4 ◦ C for 20 min) and the supernatant was
collected. A commercial ELISA kit was utilized to evaluate levels of IL-1β (R&D Systems,
Inc., Minneapolis, MN, USA), the cytokine with the highest levels of expression in RT-PCR.
ELISA was analyzed in duplicate.
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2.5. Statistical Analysis
Analysis of variance (ANOVA) and regression techniques ((SAS/STAT Software 9.4,
SAS Institute, Inc., Cary, NC, USA; SPSS Statistics 27, IBM Corp., Somer, NY, USA; GraphPad Software, Inc., La Jolla, CA, USA) were utilized for the statistical analysis of all data.
Statistical significance was set at an alpha criterion of p ≤ 0.05.
Multiple dependent measures were utilized to evaluate the impact of chronic HIV1 viral protein exposure, biological sex, and/or age on regressive processes, including
dendrite and synaptic pruning. To evaluate the progression of neuronal arbor complexity,
area under the Sholl curve was derived from the classic Sholl intersection profile for each
animal at every age. A mixed-model ANOVA with a compound symmetry covariance
structure (PROC MIXED; SAS/STAT Software 9.4) was utilized to statistically analyze the
area under the Sholl curve. The classic Sholl intersection profile was analyzed using a
mixed-model ANOVA with a variance components covariance structure (PROC MIXED;
SAS/STAT Software 9.4), as recommended by Wilson et al. [49]. The total number of
dendritic branches, an index of dendritic branching complexity, and dendritic spines, a
measure of excitatory synapses, were evaluated using a generalized linear mixed-effects
model with a Poisson distribution and unstructured covariance structure (PROC GLIMMIX;
SAS/STAT Software 9.4). Complementary regression techniques (GraphPad Software,
Inc.) were also used to assess the development of apical dendrite length, neuronal arbor
complexity, dendritic branching complexity, and excitatory synapses.
Synaptic connectivity was assessed by evaluating the number of dendritic spines
between each successive radii. Three measures of dendritic spine morphology, including
dendritic spine volume, backbone length, and head diameter, were analyzed by examining
the number of dendritic spines within each bin. A generalized linear mixed-effects model
with a Poisson distribution and an unstructured covariance pattern was conducted using
PROC GLIMMIX (SAS/STAT Software 9.4) for both synaptic connectivity and dendritic
spine morphological parameters. The statistical analyses for dendritic spine backbone
length were conducted for bins from 0.4 µm to 2.0 µm. Furthermore, the statistical analyses
for dendritic spine head diameter were conducted for dendritic spines with a head diameter
greater than 0.01 µm. Radii and bin served as within-subjects factors, as appropriate,
whereas genotype (HIV-1 Tg vs. Control), biological sex (Male vs. Female), and age
(Synaptic Connectivity: PD 30 vs. PD 180; Dendritic Spine Morphology: PD 30, PD 60, PD
90, PD 120, PD 150, PD 180) served as between-subjects factors.
Putative neuroinflammatory markers were examined using two complementary measures, including RT-PCR and ELISA. For RT-PCR, gene expression was investigated using
∆CT, which was calculated by subtracting the gene of interest from the internal control (i.e.,
β-actin). ∆CT was analyzed independently for each neuroinflammatory marker using a
mixed-model ANOVA (PROC MIXED; SAS/STAT Software 9.4). Interactions were further
evaluated using simple effects in the context of the overall analysis. For ELISA, the concentration was averaged across the two duplicates to account for the nested data structure
and analyzed using a mixed-model ANOVA (SPSS Statistics 27). Genotype (HIV-1 Tg vs.
Control) and biological sex (Male vs. Female) served as between-subjects factors.
3. Results
3.1. Experiment #1: Neurodevelopmental Alterations in the Medial Prefrontal Cortex (mPFC)
3.1.1. Presence of HIV-1 Viral Proteins Results in Abnormal Development and Patterning
of Dendritic Branches
HIV-1 Tg animals displayed prominent alterations in the development and patterning
of apical dendrites in pyramidal neurons in layers II-III of the mPFC, evidenced by three
complementary measures of neuronal morphology (i.e., Dendrite Length, Figure 3A; Sholl
Analysis, Figure 3B; Dendritic Branching, Figure 3C).

Furthermore, profound alterations in the branching complexity of dendrites were observed in HIV-1 Tg animals relative to controls (Figure 3C; Genotype × Age interaction,
F(5, 200) = 2.4, p ≤ 0.04)). HIV-1 Tg animals exhibited a progressive increase in the total
number of dendritic branches throughout development (Best Fit: First-Order Polynomial,
R2 ≥ 0.96); a sharp contrast to the stable number of total dendritic branches observed in
8 of 19
control animals. Taken together, HIV-1 Tg animals exhibited enhanced neuronal arbor
and branching complexity across development relative to control animals.
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A differential progression, dependent upon genotype, was observed in both apical
dendrite length (Figure 3A) and the area under the Sholl curve (Figure 3B; Genotype ×
Age interaction, F(5, 200) = 2.6, p ≤ 0.03). Specifically, in control animals, apical dendrite
length and the classical Sholl analysis revealed initial neuronal arbor elaboration (i.e., PD
30) followed by dendritic pruning during adolescence (i.e., PD 60) and the stabilization of
the neuronal arbor (i.e., PD 90–180; Best Fit: Segmental Linear Regression, R2 ≥ 0.84 and
R2 ≥ 0.87 for apical dendrite length and area under the Sholl curve, respectively). In HIV-1
Tg animals, however, a linear increase in both apical dendrite length and neuronal arbor
complexity was observed across development (Best Fit: First-Order Polynomial, R2 ≥ 0.71
and R2 ≥ 0.83 for apical dendrite length and area under the Sholl curve, respectively).
Critically, with regards to the Sholl analysis, examination of the Sholl intersection profile
revealed consistent observations (Supplementary Figure S2; Genotype × Age × Radius
interaction, F(5, 5352) = 3.1, p ≤ 0.01).
Furthermore, profound alterations in the branching complexity of dendrites were
observed in HIV-1 Tg animals relative to controls (Figure 3C; Genotype × Age interaction,
F(5, 200) = 2.4, p ≤ 0.04)). HIV-1 Tg animals exhibited a progressive increase in the total
number of dendritic branches throughout development (Best Fit: First-Order Polynomial,
R2 ≥ 0.96); a sharp contrast to the stable number of total dendritic branches observed in
control animals. Taken together, HIV-1 Tg animals exhibited enhanced neuronal arbor and
branching complexity across development relative to control animals.
3.1.2. HIV-1 Tg Animals Exhibited a Linear Increase in the Number of Dendritic Spines, a
Proxy for the Number of Excitatory Synapses, across Development
Given that dendritic spines typically contain a single type 1 asymmetric synapse, the
total number of dendritic spines may serve as a proxy for the number of excitatory synapses
(for review, [50]). A differential progression, dependent upon genotype, was observed
in the total number of dendritic spines across development (Figure 4; Genotype × Age
Interaction, F(5, 200) = 9.9, p ≤ 0.001). Specifically, control rats, independent of biological
sex, exhibited an initial overproduction of dendritic spines (i.e., PD 30) followed by pruning
during adolescence (i.e., PD 60) and the stabilization of dendritic spines during adulthood
(i.e., PD 90–180; Best Fit: Segmental Linear Regression, R2 ≥ 0.87). In sharp contrast, HIV-1
Tg animals exhibited a linear increase in the number of dendritic spines across development
(Best Fit: First-Order Polynomial, R2 ≥ 0.92). Thus, independent of biological sex, presence
of the HIV-1 transgene alters synaptogenesis, including the establishment, maintenance,
and elimination of synapses.

pruning during adolescence (i.e., PD 60) and the stabilization of dendritic spines during
adulthood (i.e., PD 90–180; Best Fit: Segmental Linear Regression, R2 ≥ 0.87). In sharp contrast, HIV-1 Tg animals exhibited a linear increase in the number of dendritic spines across
development (Best Fit: First-Order Polynomial, R2 ≥ 0.92). Thus, independent of biological
sex, presence of the HIV-1 transgene alters synaptogenesis, including the establishment,
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maintenance, and elimination of synapses.

Number of Dendritic
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age, HIV× Radii Interaction, F(1, 1816) = 40.3, p ≤ 0.001). Specifically, independent of age, HIV-1 Tg
animals displayed a preponderance of dendritic spines on more distal dendrites relative
to control animals; albeit a more pronounced rightward shift was observed at PD 180.
Furthermore, it is notable that the factor of biological sex also influenced the magnitude,
but not the pattern, of the distributional shift (Genotype × Age × Sex × Radii Interaction,
F(1, 1816) = 154.6, p ≤ 0.001). Results support, therefore, a developmental decrease in
synaptic connectivity in HIV-1 Tg animals.
3.1.4. HIV-1 Tg Rats Exhibited Progressive Dendritic Spine Dysmorphology, Evidenced by
Developmental Alterations in Dendritic Spine Volume, Backbone Length, and Head
Diameter
HIV-1 Tg animals exhibited a progressive decrease in dendritic spine volume throughout development; a sharp contrast to the age-related increase observed in control animals
(Figure 5A; Best Fit: First-Order Polynomial, R2 s ≥ 0.54). Furthermore, examination of
the distribution of dendritic spines (Figure 5B) confirmed the differential development of
dendritic spine volume (Genotype × Age × Bin Interaction, F(80, 3200) = 3.2, p ≤ 0.001).
Specifically, at PD 30, PD 60, and PD 90 HIV-1 Tg animals exhibited a prominent population
shift towards increased dendritic spine volume relative to control animals. At PD 120, PD
150, and PD 180, however, a profound population shift towards decreased dendritic spine

animals (Figure 5A; Best Fit: First-Order Polynomial, R2s ≥ 0.54). Furthermore, examination of the distribution of dendritic spines (Figure 5B) confirmed the differential development of dendritic spine volume (Genotype × Age × Bin Interaction, F(80, 3200) = 3.2, p ≤
0.001). Specifically, at PD 30, PD 60, and PD 90 HIV-1 Tg animals exhibited a prominent
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PD 120, PD 150, and PD 180, however, a profound population shift towards decreased
dendritic spine volume was observed in HIV-1 Tg, relative to control, animals. The factor
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Examination of the distribution of dendritic spine backbone length (Figure 6A; Genotype × Age × Bin Interaction, F(80, 3200) = 14.8, p ≤ 0.001) and head diameter (Figure 6B;
F(55, 2200) = 28.3, p ≤ 0.001) afford additional support for progressive dendritic spine
dysmorphology in HIV-1 Tg animals. Specifically, at PD 30, PD 60, and PD 90 HIV-1 Tg
animals exhibited a prominent population shift towards shorter dendritic spines with increased head diameter relative to control animals. At PD 120, PD 150, and PD 180, however,
a profound population shift towards longer dendritic spines with decreased head diameter
was observed in HIV-1 Tg, relative to control, animals.

F(55, 2200) = 28.3, p ≤ 0.001) afford additional support for progressive dendritic spine dysmorphology in HIV-1 Tg animals. Specifically, at PD 30, PD 60, and PD 90 HIV-1 Tg animals exhibited a prominent population shift towards shorter dendritic spines with increased head diameter relative to control animals. At PD 120, PD 150, and PD 180, however, a profound population shift towards longer dendritic spines with decreased11head
of 19
diameter was observed in HIV-1 Tg, relative to control, animals.
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Figure 6. Dendritic spine dysmorphology in pyramidal neurons from layers II-III of the medial prefrontal cortex in the
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3.2. Experiment #2: Neuroinflammatory Markers in the Medial Prefrontal Cortex
There Is No Compelling Evidence for Neuroinflammation in the mPFC of HIV-1 Tg
Rats during Early Development
Three putative neuroinflammatory markers, including IL-1β, IL-6, and TNF-α, were
examined at PD 30 using RT-PCR. Overall, independent of genotype and/or biological sex,
low levels of gene expression were observed, evidenced by cycle threshold (CT) values
ranging from 26.1 to 40 for IL-1β, from 31.3 to 40 for IL-6 and from 25.7 to 40 for TNF-α.
Data are presented as ∆CT values (i.e., Internal Control (β-actin)–Gene of Interest), whereby
higher ∆CT values indicate lower gene expression and lower ∆CT values represent higher
gene expression. With regards to IL-1β, a higher level of gene expression was observed
in female animals, independent of genotype, relative to male animals (Figure 7A; Main
Effect: Sex, F(1, 35) = 5.5, p ≤ 0.03). Examination of IL-6 revealed a statistically significant

sent higher gene expression. With regards to IL-1β, a higher level of gene expression was
observed in female animals, independent of genotype, relative to male animals (Figure
7A; Main Effect: Sex, F(1,35) = 5.5, p ≤ 0.03). Examination of IL-6 revealed a statistically
significant main effect of genotype (Figure 7B; F(1,29) = 6.2, p ≤ 0.02), whereby HIV-1 Tg
animals, independent of biological sex, exhibited a lower level of gene expression relative
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to control animals. For TNF-α, gene expression was dependent upon an interaction between genotype and biological sex (Figure 7C; F(1, 33) = 5.6 p ≤ 0.02); an interaction resulting from decreased gene expression in HIV-1 Tg male animals relative to control male rats
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4. Discussion
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opmental alterations in the HIV-1 Tg rat were evidenced by prominent deficits in dendritic
and synaptic pruning, processes that are a hallmark of adolescent brain maturation (for
review, [51]). Progressive synaptodendritic dysfunction was evidenced by an examination of the continuous morphological parameters of dendritic spines. Specifically, HIV-1
Tg animals exhibited an age-related population shift towards dendritic spines with decreased volume, increased backbone length, and decreased head diameter; parameters
associated with a more immature dendritic spine phenotype. Based on an examination
of three putative neuroinflammatory markers early in development (i.e., PD 30), there
was no compelling evidence for neuroinflammation in the mPFC of HIV-1 Tg rats. Collectively, progressive neuronal and dendritic spine dysmorphology herald synaptodendritic
dysfunction as a key neural mechanism underlying chronic neurocognitive impairments
in pALHIV.
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three putative neuroinflammatory markers early in development (i.e., PD 30), there was
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Under homeostatic conditions, microglia exhibit a ramified morphology with small somas and highly branched processes supporting constant environmental surveillance [56,57];
surveillance which is uniquely targeted to synaptic structures, including dendritic
spines [58,59]. During brain development, microglia are involved in the phagocytic and/or
trogocytotic elimination of neurites (e.g., [60–62]) and synapses (e.g., [63–65]). Proteins and
receptors expressed by microglia (e.g., complement component 1q (C1q) [66]; complement
receptor 3 (CR3) [67]; CX3C chemokine receptor 1 (Cx3cr1) [68,69]), have been implicated
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as potential mechanisms underlying microglia-mediated neurite and pre- and postsynaptic
engulfment [61–64,70]. Specifically, genetic deletion of C1q [70], CR3 [64], or Cx3cr1 [61,63]
precludes neurite and/or synaptic pruning. Furthermore, increasing or decreasing the
activity level of the complement system results in either excessive or impaired neurite
pruning, respectively [62]. Critically, the complement system and Cx3cr1 are dysregulated
by HIV-1 viral proteins [71,72] and associated with neuronal injury in HIV-1 seropositive individuals [73]; alterations that support a convergent mechanism underlying the prominent
alterations in regressive processes observed in the HIV-1 Tg rat.
After synaptic pruning, the remaining synapses are functionally strengthened and
elaborated to aid in the formation of mature neural circuits. The PFC is highly connected
with other cortical and subcortical regions making it well suited to serve as a central hub,
integrating and relaying information throughout the brain (for review, [74]). In addition
to excitatory glutamatergic and inhibitory gamma-aminobutyric acid afferents, the PFC
is densely innervated by dopaminergic, noradrenergic, and serotonergic projections from
multiple brain regions (i.e., ventral tegmental area, locus coeruleus, and dorsal and median raphe nuclei, respectively [14]). The vast majority of afferent projections synapse on
dendritic spines of pyramidal neurons [75] supporting their fundamental role in neural
circuits. Therefore, two complementary approaches were utilized to establish the progression of dendritic spine alterations in the HIV-1 Tg rat, including an examination of their
distribution and an evaluation of their morphological parameters.
Independent of age (i.e., PD 30 or PD 180), HIV-1 Tg animals exhibited a prominent
rightward shift in the distribution of dendritic spines along the apical dendrite relative to
controls; an observation that supports an alteration in synaptic connectivity. Architecturally,
the PFC is organized in a laminar fashion from superficial (i.e., Layer I) to deep (i.e., Layer
VI [14]); pyramidal neurons from layers II-III of the mPFC extend superficially into layer
I. Dopaminergic, noradrenergic, and serotonergic receptors are abundantly expressed in
layers II-III, but not layer I, of the mPFC [76]. In HIV-1 Tg rats, therefore, the preponderance
of dendritic spines on distal dendrites, which extend into layer I, supports alterations in
neurotransmitter innervation and synaptic connectivity. Indeed, neurotransmitter systems, including the dopamine (for review, [77]), norepinephrine (e.g., [78]) and serotonin
(e.g., [79,80]) systems, are dysregulated by HIV-1 viral protein exposure. Furthermore,
the magnitude of the rightward shift in the distribution of dendritic spines along the
apical dendrite progresses with age in HIV-1 Tg animals, supporting an age-related loss in
neurotransmitter innervation and synaptic connectivity.
With regards to the morphological parameters of dendritic spines, a discrete classification system, consisting of four categories (i.e., filopodia, mushroom, stubby, thin), has been
traditionally utilized to characterize dendritic spines [81]. Mushroom spines, which are
considered the most mature morphology (for review, [50]), contain a large dendritic spine
head and small dendritic spine neck [81]. Stable mushroom spines form strong synaptic
connections, evidenced, at least in part, by their large postsynaptic densities and high
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) to N- methyl-D-aspartate
(NMDA) ratios [50]. Dendritic spines classified as either stubby (i.e., absence of a dendritic
spine neck) or thin (i.e., long, thin dendritic spine neck and a smaller dendritic spine
head), however, are considered immature dendritic spines. Although both stubby and thin
spines contain synaptic structures, they have lower AMPA to NMDA ratios and are more
transient [50]. Filopodia-like structures, which lack a clear type 1 synapse [82], are regarded
as the most immature type of dendritic protrusion [50]. Based on these categorizations,
the predominant dendritic spine morphology in HIV-1 Tg animals regresses from a mature ‘mushroom’ phenotype to an immature ‘thin’ phenotype across time. More recently,
however, it has been recognized that spine morphology is more accurately assessed by
continuous numerical measures (e.g., [46,47]), as in the current study.
Indeed, the examination of continuous dendritic spine morphological parameters
adds additional credence for progressive synaptodendritic dysfunction in the HIV-1 Tg
rat. Continuous morphological measurements have revealed the tight coupling between
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dendritic spine structure and synaptic function [46,83–85]. Specifically, increased total
dendritic spine volume is strongly associated with increased area of the postsynaptic
density (PSD; r = 0.51 to 0.88; [46,83,84]). Furthermore, the dendritic spine head is positively
correlated with both the area of the PSD (r = 0.88; [46,84]) and the number of synaptic
vesicles (r = 0.92; [84]). In sharp contrast, dendritic spine neck length is negatively correlated
with synaptic efficacy (r = −0.72; [85]). HIV-1 Tg animals exhibited an age-related decrease
in dendritic spine volume and head diameter, as well as an age-related increase in backbone
length; a population shift supporting a developmental decrease in synaptic function.
Despite the power of continuous dendritic spine morphological measurements, a few
caveats must be acknowledged. First, electrophysiological recordings of pyramidal neurons
in the mPFC were not conducted in the present study. However, recent observations
of increased intrinsic excitability in pyramidal neurons from layers II-III of the mPFC
following HIV-1 Tat expression [86] support alterations in the neural circuitry evaluated
herein. Second, there was also an absence of biochemical analyses, including measurements
of PSD-95 and/or SAP102, to measure synaptic function. However, decreased expression
of PSD-95 has been previously reported following exposure to HIV-1 Tat [87]; inferences
drawn from the rigorous morphological assessment of dendritic spines, therefore, are
consistent with previous findings.
Notably, the neurodevelopmental alterations in regressive processes and synaptic
function occurred in the absence of any significant neuroinflammation early in development; findings which are consistent with our current knowledge of the clinical syndrome in
the post-cART era. Inflammatory markers measured in the periphery (e.g., blood samples)
of children perinatally infected with HIV-1 are significantly elevated relative to controls
(e.g., [88–90]). Peripheral inflammation, however, is distinct from neuroinflammation (e.g.,
measurements from cerebrospinal fluid (CSF)) evidenced by limited concordance between
plasma and CSF immunological markers in children perinatally infected with HIV-1 [90].
Indeed, in the CSF of HIV-1 seropositive children, multiple proinflammatory markers
are undetectable [91].
In conclusion, constitutive expression of HIV-1 viral proteins induced profound neurodevelopmental alterations and progressive synaptodendritic dysfunction, independent
of biological sex, in pyramidal neurons from layers II-III of the mPFC. Neurodevelopmental
alterations in the HIV-1 Tg rat were characterized by aberrant neurite and synaptic pruning.
Progressive synaptodendritic dysfunction was evidenced by an age-related decrease in
synaptic connectivity and a population shift towards a more immature dendritic spine
phenotype. Collectively, progressive neuronal and dendritic spine dysmorphology herald
synaptodendritic dysfunction as a key neural mechanism underlying chronic neurocognitive impairments in pALHIV.
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